Genetics & Genomics

March 5, 2026

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.

February 25, 2026

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

By Jake Lowary
February 24, 2026

Study identifies medical conditions that could predict future Alzheimer’s disease

The findings could suggest ways to intervene before clinical symptoms of memory and cognitive impairment become apparent.

By Leigh MacMillan
February 6, 2026

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

By Leigh MacMillan
Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)
February 4, 2026

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

By Bill Snyder
(iStock)
January 16, 2026

Study finds so-called super agers tend to have at least two key genetic advantages

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.

By Paul Govern
January 7, 2026

Study identifies potential target for blood cancer treatment, prevention

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.
By Bill Snyder
December 23, 2025

Annet Kirabo named “Top Scholar” in hypertension

By Bill Snyder
December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.
By Leigh MacMillan
November 17, 2025

New grant supports epilepsy study in Africa’s Sahel region

In this area, treatment gaps affect up to 96% of patients, leaving millions without care. The project is funded by the National Institute of Neurological Disorders and Stroke of the NIH. 
By Kristin Centers
November 7, 2025

Martha Dudek receives Strategic Leader Award from National Society of Genetic Counselors

This award honors a genetic counselor who “advances genetic counseling as a vital part of health care through education, research or public policy.
By Danny Bonvissuto
October 30, 2025

Genetic variation impact scores: A new tool for earlier heart disease detection

The study will go a long way to improving the early diagnosis and treatment of familial hypercholesterolemia, a common genetic driver of cardiovascular disease.
By Bill Snyder
October 29, 2025

New genetic marker found to predict severe gout drug reactions in US patients

The discovery could improve safety of allopurinol for millions by expanding genetic screening.
By Craig Boerner